Literature DB >> 21877201

Patients with cirrhosis and ascites have false values of bone density: implications for the diagnosis of osteoporosis.

N Guañabens1, A Monegal, A Muxi, A Martinez-Ferrer, R Reyes, J Caballería, L Del Río, P Peris, F Pons, A Parés.   

Abstract

UNLABELLED: The effect of ascites on bone densitometry has been assessed in 25 patients with advanced cirrhosis, and it was concluded that ascites over 4 l causes inaccuracy of BMD measurements, particularly at the lumbar spine. This fact must be considered when assessing bone mass in patients with decompensated cirrhosis.
INTRODUCTION: Bone mineral density (BMD) measured by dual-energy x-ray absorptiometry (DXA) is the best procedure for assessment of osteoporosis and fracture risk, but BMD values at the central skeleton may be influenced by changes in soft tissues. Therefore, we have studied the effect of ascites on BMD.
METHODS: BMD was measured by DXA at the lumbar spine, femoral neck and total hip, just before and shortly after therapeutic paracentesis in 25 patients with advanced liver cirrhosis. Changes in BMD, lean and fat mass, abdominal diameter and weight, as well as the amount of removed ascites were measured.
RESULTS: The amount of drained ascites was 6.6 ± 0.5 l (range: 3.0 to 12.7 l). After paracentesis, BMD increased at the lumbar spine (from 0.944 ± 0.035 to 0.997 ± 0.038 g/cm(2), p < 0.001) and at the total hip (from 0.913 ± 0.036 to 0.926 ± 0.036 g/cm(2), p < 0.01). Patients with a volume of drained ascites higher than 4 l showed a significant increase in lumbar BMD (7.0%), compared with patients with a lower amount (1.5%) (p < 0.03). The decrease in total soft tissue mass correlated with the amount of removed ascites (r = 0.951, p < 0.001). Diagnosis of osteoporosis or osteopenia changed after paracentesis in 12% of patients.
CONCLUSION: Ascites over 4 l causes inaccuracy of BMD measurements, particularly at the lumbar spine. This fact must be considered when assessing bone mass in patients with advanced cirrhosis.

Entities:  

Mesh:

Year:  2011        PMID: 21877201     DOI: 10.1007/s00198-011-1756-1

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  29 in total

1.  Bone disease after liver transplantation: a long-term prospective study of bone mass changes, hormonal status and histomorphometric characteristics.

Authors:  A Monegal; M Navasa; N Guañabens; P Peris; F Pons; M J Martinez de Osaba; J Ordi; A Rimola; J Rodés; J Muñoz-Gómez
Journal:  Osteoporos Int       Date:  2001       Impact factor: 4.507

2.  American Gastroenterological Association medical position statement: osteoporosis in hepatic disorders.

Authors: 
Journal:  Gastroenterology       Date:  2003-09       Impact factor: 22.682

3.  Dual-energy X-ray absorptiometry: fat estimation errors due to variation in soft tissue hydration.

Authors:  A Pietrobelli; Z Wang; C Formica; S B Heymsfield
Journal:  Am J Physiol       Date:  1998-05

4.  Influence of changes in peritoneal fluid on body-composition measurements by dual-energy X-ray absorptiometry in patients receiving continuous ambulatory peritoneal dialysis.

Authors:  G Woodrow; B Oldroyd; J H Turney; M A Smith
Journal:  Am J Clin Nutr       Date:  1996-08       Impact factor: 7.045

5.  Does paracentesis of ascites influence measurements of bone mineral or body composition by dual-energy x-ray absorptiometry?

Authors:  K V Haderslev; O L Svendsen; M Staun
Journal:  Metabolism       Date:  1999-03       Impact factor: 8.694

6.  Anomalies in the measurement of changes in total-body bone mineral by dual-energy X-ray absorptiometry during weight change.

Authors:  P Tothill; W J Hannan; S Cowen; C P Freeman
Journal:  J Bone Miner Res       Date:  1997-11       Impact factor: 6.741

7.  Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

Authors:  U A Liberman; S R Weiss; J Bröll; H W Minne; H Quan; N H Bell; J Rodriguez-Portales; R W Downs; J Dequeker; M Favus
Journal:  N Engl J Med       Date:  1995-11-30       Impact factor: 91.245

8.  Bone loss accompanying voluntary weight loss in obese humans.

Authors:  L B Jensen; F Quaade; O H Sørensen
Journal:  J Bone Miner Res       Date:  1994-04       Impact factor: 6.741

9.  Pamidronate in the prevention of bone loss after liver transplantation: a randomized controlled trial.

Authors:  Ana Monegal; Núria Guañabens; María Jesús Suárez; Francisco Suárez; Gerardo Clemente; Miguel García-González; Manuel De la Mata; Trinidad Serrano; Fernando Casafont; Santiago Tome; Santiago Torne; Cesar Barrios; Miquel Navasa
Journal:  Transpl Int       Date:  2008-09-15       Impact factor: 3.782

10.  Effect of ascites on bone density measurement in cirrhosis.

Authors:  Eternity D Labio; Dante B Del Rosario; Simone I Strasser; Geoffrey W McCaughan; Bronwyn A Crawford
Journal:  J Clin Densitom       Date:  2007-08-20       Impact factor: 2.617

View more
  9 in total

Review 1.  Hepatic osteodystrophy.

Authors:  Angelo Gatta; Alberto Verardo; Marco Di Pascoli; Sandro Giannini; Massimo Bolognesi
Journal:  Clin Cases Miner Bone Metab       Date:  2014-09

Review 2.  Fragility fracture risk in cirrhosis: a comparison of the fracture risk assessment tool, British Society of Gastroenterology and National Institute for Health and Clinical Excellence guidelines.

Authors:  Lachlan Richard Owen Ayres; Shane Clarke; Jonathan Digby-Bell; Ashwin Deep Dhanda; Suranga Dharmasiri; Katharine Caddick; Peter Lesley Collins
Journal:  Frontline Gastroenterol       Date:  2012-07-12

Review 3.  EASL Clinical Practice Guidelines on nutrition in chronic liver disease.

Authors: 
Journal:  J Hepatol       Date:  2018-08-23       Impact factor: 25.083

4.  Evidence of degraded BMD and geometry at the proximal femora in male patients with alcoholic liver cirrhosis.

Authors:  Dj Culafić; D Djonic; V Culafic-Vojinovic; S Ignjatovic; I Soldatovic; J Vasic; T J Beck; M Djuric
Journal:  Osteoporos Int       Date:  2014-08-30       Impact factor: 4.507

Review 5.  Osteoporosis in liver disease: pathogenesis and management.

Authors:  Gabriela Handzlik-Orlik; Michał Holecki; Krzysztof Wilczyński; Jan Duława
Journal:  Ther Adv Endocrinol Metab       Date:  2016-04-06       Impact factor: 3.565

Review 6.  Sarcopenia and liver transplant: The relevance of too little muscle mass.

Authors:  Eric R Kallwitz
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

Review 7.  Diagnosis and Management of Cirrhosis-Related Osteoporosis.

Authors:  Lívia Alves Amaral Santos; Fernando Gomes Romeiro
Journal:  Biomed Res Int       Date:  2016-10-20       Impact factor: 3.411

Review 8.  Nutrition in Chronic Liver Disease: Consensus Statement of the Indian National Association for Study of the Liver.

Authors:  Pankaj Puri; Radha K Dhiman; Sunil Taneja; Puneeta Tandon; Manuela Merli; Anil C Anand; Anil Arora; Subrat K Acharya; Jaya Benjamin; Yogesh K Chawla; Sunil Dadhich; Ajay Duseja; C E Eapan; Amit Goel; Naveen Kalra; Dharmesh Kapoor; Ashish Kumar; Kaushal Madan; Aabha Nagral; Gaurav Pandey; Padaki N Rao; Sanjiv Saigal; Neeraj Saraf; Vivek A Saraswat; Anoop Saraya; Shiv K Sarin; Praveen Sharma; Akash Shukla; Sandeep S Sidhu; Namrata Singh; Shivaram P Singh; Anshu Srivastava; Manav Wadhawan
Journal:  J Clin Exp Hepatol       Date:  2020-10-01

9.  Quantification of Abdominal Muscle Mass and Diagnosis of Sarcopenia with Cross-Sectional Imaging in Patients with Polycystic Kidney Disease: Correlation with Total Kidney Volume.

Authors:  Chih-Horng Wu; Tai-Shuan Lai; Yung-Ming Chen; Chyi-Mong Chen; Shun-Chung Yang; Po-Chin Liang
Journal:  Diagnostics (Basel)       Date:  2022-03-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.